HEADER TRANSFERASE 16-JAN-08 3BYU TITLE CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: P56-LCK, LYMPHOCYTE CELL-SPECIFIC PROTEIN-TYROSINE KINASE, COMPND 6 LSK, T CELL-SPECIFIC PROTEIN-TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LCK; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: INSECT CELL KEYWDS LCK, KINASE DOMAIN, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL KEYWDS 2 REARRANGEMENT, CYTOPLASM, DISEASE MUTATION, HOST-VIRUS INTERACTION, KEYWDS 3 LIPOPROTEIN, MEMBRANE, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, KEYWDS 4 PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, SH3 DOMAIN, TRANSFERASE, KEYWDS 5 TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR X.HUANG REVDAT 5 30-AUG-23 3BYU 1 REMARK REVDAT 4 09-JUN-09 3BYU 1 REVDAT REVDAT 3 24-FEB-09 3BYU 1 VERSN REVDAT 2 30-DEC-08 3BYU 1 JRNL REVDAT 1 16-SEP-08 3BYU 0 JRNL AUTH E.F.DIMAURO,J.NEWCOMB,J.J.NUNES,J.E.BEMIS,C.BOUCHER,L.CHAI, JRNL AUTH 2 S.C.CHAFFEE,H.L.DEAK,L.F.EPSTEIN,T.FAUST,P.GALLANT,A.GORE, JRNL AUTH 3 Y.GU,B.HENKLE,F.HSIEH,X.HUANG,J.L.KIM,J.H.LEE,M.W.MARTIN, JRNL AUTH 4 D.C.MCGOWAN,D.METZ,D.MOHN,K.A.MORGENSTERN, JRNL AUTH 5 A.OLIVEIRA-DOS-SANTOS,V.F.PATEL,D.POWERS,P.E.ROSE, JRNL AUTH 6 S.SCHNEIDER,S.A.TOMLINSON,Y.Y.TUDOR,S.M.TURCI,A.A.WELCHER, JRNL AUTH 7 H.ZHAO,L.ZHU,X.ZHU JRNL TITL STRUCTURE-GUIDED DESIGN OF AMINOPYRIMIDINE AMIDES AS POTENT, JRNL TITL 2 SELECTIVE INHIBITORS OF LYMPHOCYTE SPECIFIC KINASE: JRNL TITL 3 SYNTHESIS, STRUCTURE-ACTIVITY RELATIONSHIPS, AND INHIBITION JRNL TITL 4 OF IN VIVO T CELL ACTIVATION. JRNL REF J.MED.CHEM. V. 51 1681 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18321037 JRNL DOI 10.1021/JM7010996 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 14892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 755 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 126 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.750 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BYU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046127. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14892 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.20400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1QPC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE, 20% (V/V) REMARK 280 ISOPROPANOL, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.06000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.75000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.86000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.75000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.06000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.86000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 225 REMARK 465 THR A 226 REMARK 465 GLN A 227 REMARK 465 LYS A 228 REMARK 465 PRO A 229 REMARK 465 GLN A 230 REMARK 465 ALA A 386 REMARK 465 ARG A 387 REMARK 465 LEU A 388 REMARK 465 ILE A 389 REMARK 465 GLU A 390 REMARK 465 ASP A 391 REMARK 465 ASN A 392 REMARK 465 GLU A 393 REMARK 465 TYR A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ARG A 397 REMARK 465 GLU A 398 REMARK 465 GLY A 399 REMARK 465 ALA A 400 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 309 CG CD OE1 NE2 REMARK 470 LYS A 401 CG CD CE NZ REMARK 470 PHE A 402 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 451 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 403 C - N - CA ANGL. DEV. = 12.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 253 -166.79 -116.78 REMARK 500 GLN A 255 -73.73 -44.28 REMARK 500 ALA A 305 -176.01 -173.52 REMARK 500 ARG A 363 -12.38 76.26 REMARK 500 ASP A 364 44.62 -147.55 REMARK 500 ASP A 382 101.50 -160.75 REMARK 500 PRO A 403 27.46 -31.76 REMARK 500 ILE A 404 -78.71 61.22 REMARK 500 LYS A 405 -28.73 -39.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 591 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AM6 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OFV RELATED DB: PDB REMARK 900 RELATED ID: 3BYS RELATED DB: PDB DBREF 3BYU A 225 501 UNP P06239 LCK_HUMAN 225 501 SEQRES 1 A 277 GLN THR GLN LYS PRO GLN LYS PRO TRP TRP GLU ASP GLU SEQRES 2 A 277 TRP GLU VAL PRO ARG GLU THR LEU LYS LEU VAL GLU ARG SEQRES 3 A 277 LEU GLY ALA GLY GLN PHE GLY GLU VAL TRP MET GLY TYR SEQRES 4 A 277 TYR ASN GLY HIS THR LYS VAL ALA VAL LYS SER LEU LYS SEQRES 5 A 277 GLN GLY SER MET SER PRO ASP ALA PHE LEU ALA GLU ALA SEQRES 6 A 277 ASN LEU MET LYS GLN LEU GLN HIS GLN ARG LEU VAL ARG SEQRES 7 A 277 LEU TYR ALA VAL VAL THR GLN GLU PRO ILE TYR ILE ILE SEQRES 8 A 277 THR GLU TYR MET GLU ASN GLY SER LEU VAL ASP PHE LEU SEQRES 9 A 277 LYS THR PRO SER GLY ILE LYS LEU THR ILE ASN LYS LEU SEQRES 10 A 277 LEU ASP MET ALA ALA GLN ILE ALA GLU GLY MET ALA PHE SEQRES 11 A 277 ILE GLU GLU ARG ASN TYR ILE HIS ARG ASP LEU ARG ALA SEQRES 12 A 277 ALA ASN ILE LEU VAL SER ASP THR LEU SER CYS LYS ILE SEQRES 13 A 277 ALA ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU SEQRES 14 A 277 TYR THR ALA ARG GLU GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 A 277 THR ALA PRO GLU ALA ILE ASN TYR GLY THR PHE THR ILE SEQRES 16 A 277 LYS SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU SEQRES 17 A 277 ILE VAL THR HIS GLY ARG ILE PRO TYR PRO GLY MET THR SEQRES 18 A 277 ASN PRO GLU VAL ILE GLN ASN LEU GLU ARG GLY TYR ARG SEQRES 19 A 277 MET VAL ARG PRO ASP ASN CYS PRO GLU GLU LEU TYR GLN SEQRES 20 A 277 LEU MET ARG LEU CYS TRP LYS GLU ARG PRO GLU ASP ARG SEQRES 21 A 277 PRO THR PHE ASP TYR LEU ARG SER VAL LEU GLU ASP PHE SEQRES 22 A 277 PHE THR ALA THR HET AM6 A 1 44 HETNAM AM6 2-METHYL-N-{4-METHYL-3-[(2-{[4-(4-METHYLPIPERAZIN-1- HETNAM 2 AM6 YL)PHENYL]AMINO}PYRIMIDIN-5-YL)CARBAMOYL]PHENYL}-3- HETNAM 3 AM6 (TRIFLUOROMETHYL)BENZAMIDE FORMUL 2 AM6 C32 H32 F3 N7 O2 FORMUL 3 HOH *126(H2 O) HELIX 1 1 PRO A 241 GLU A 243 5 3 HELIX 2 2 SER A 281 GLN A 294 1 14 HELIX 3 3 SER A 323 LEU A 328 1 6 HELIX 4 4 THR A 330 LYS A 335 1 6 HELIX 5 5 THR A 337 ARG A 358 1 22 HELIX 6 6 ARG A 366 ALA A 368 5 3 HELIX 7 7 ALA A 408 GLY A 415 1 8 HELIX 8 8 THR A 418 THR A 435 1 18 HELIX 9 9 THR A 445 GLY A 456 1 12 HELIX 10 10 PRO A 466 TRP A 477 1 12 HELIX 11 11 ARG A 480 ARG A 484 5 5 HELIX 12 12 THR A 486 THR A 499 1 14 SHEET 1 A 5 LEU A 245 GLY A 252 0 SHEET 2 A 5 GLY A 257 TYR A 264 -1 O VAL A 259 N LEU A 251 SHEET 3 A 5 THR A 268 LEU A 275 -1 O VAL A 270 N GLY A 262 SHEET 4 A 5 TYR A 313 GLU A 317 -1 O ILE A 314 N LYS A 273 SHEET 5 A 5 LEU A 303 VAL A 307 -1 N TYR A 304 O ILE A 315 SHEET 1 B 2 ILE A 370 VAL A 372 0 SHEET 2 B 2 CYS A 378 ILE A 380 -1 O LYS A 379 N LEU A 371 CISPEP 1 GLU A 310 PRO A 311 0 0.37 SITE 1 AC1 17 ALA A 271 LYS A 273 GLU A 288 MET A 292 SITE 2 AC1 17 LEU A 295 THR A 316 GLU A 317 TYR A 318 SITE 3 AC1 17 MET A 319 GLY A 322 TYR A 360 LEU A 371 SITE 4 AC1 17 ILE A 380 ALA A 381 ASP A 382 PHE A 383 SITE 5 AC1 17 HOH A 553 CRYST1 44.120 73.720 101.500 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022665 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013565 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009852 0.00000